Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers
-
- Henrik Möbitz
- Global Discovery Chemistry, Novartis Institutes for Biomedical Research, Basel 4002, Switzerland
-
- John Cantwell
- Novartis Institutes for Biomedical Research, 5300 Chiron Way, Emeryville, California 94608, United States
-
- Catherine Luu
- Novartis Institutes for Biomedical Research, 5300 Chiron Way, Emeryville, California 94608, United States
収録刊行物
-
- Journal of Medicinal Chemistry
-
Journal of Medicinal Chemistry 61 (22), 10155-10172, 2018-10-19
American Chemical Society (ACS)